(3S)-3-[3-[4-chloro-3-(methanesulfonamido)-1-methylindazol-7-yl]-5,8-difluoro-4-oxoquinazolin-2-yl]-2-[(2S,4R)-9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]-4-(3,5-difluorophenyl)butanamide
C35H25ClF8N8O4S — CID 156662122
Data last refreshed: (MolForge compound catalog, from PubChem)
About (3S)-3-[3-[4-chloro-3-(methanesulfonamido)-1-methylindazol-7-yl]-5,8-difluoro-4-oxoquinazolin-2-yl]-2-[(2S,4R)-9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]-4-(3,5-difluorophenyl)butanamide
(3S)-3-[3-[4-chloro-3-(methanesulfonamido)-1-methylindazol-7-yl]-5,8-difluoro-4-oxoquinazolin-2-yl]-2-[(2S,4R)-9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]-4-(3,5-difluorophenyl)butanamide (PubChem CID 156662122) has the molecular formula C35H25ClF8N8O4S and a molecular weight of 841.14 g/mol. Its IUPAC name is (3S)-3-[3-[4-chloro-3-(methanesulfonamido)-1-methylindazol-7-yl]-5,8-difluoro-4-oxoquinazolin-2-yl]-2-[(2S,4R)-9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]-4-(3,5-difluorophenyl)butanamide.
Molecular Properties
| Compound Name | (3S)-3-[3-[4-chloro-3-(methanesulfonamido)-1-methylindazol-7-yl]-5,8-difluoro-4-oxoquinazolin-2-yl]-2-[(2S,4R)-9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]-4-(3,5-difluorophenyl)butanamide |
|---|---|
| PubChem CID | 156662122 |
| Molecular Formula | C35H25ClF8N8O4S |
| Molecular Weight | 841.14 g/mol |
| Exact Mass | 840.13 |
| IUPAC Name | (3S)-3-[3-[4-chloro-3-(methanesulfonamido)-1-methylindazol-7-yl]-5,8-difluoro-4-oxoquinazolin-2-yl]-2-[(2S,4R)-9-(difluoromethyl)-5,5-difluoro-7,8-diazatricyclo[4.3.0.02,4]nona-1(6),8-dien-7-yl]-4-(3,5-difluorophenyl)butanamide |
| SMILES | Cn1nc(NS(C)(=O)=O)c2c(Cl)ccc(-n3c([C@@H](Cc4cc(F)cc(F)c4)C(C(N)=O)n4nc(C(F)F)c5c4C(F)(F)[C@@H]4C[C@H]54)nc4c(F)ccc(F)c4c3=O)c21 |
| InChI | InChI=1S/C35H25ClF8N8O4S/c1-50-28-21(6-3-18(36)23(28)32(48-50)49-57(2,55)56)51-33(46-25-20(40)5-4-19(39)24(25)34(51)54)16(9-12-7-13(37)10-14(38)8-12)27(31(45)53)52-29-22(26(47-52)30(41)42)15-11-17(15)35(29,43)44/h3-8,10,15-17,27,30H,9,11H2,1-2H3,(H2,45,53)(H,48,49)/t15-,16-,17+,27?/m0/s1 |
| InChIKey | MVOURHSMFKDFCU-HAMYFEEVSA-N |
| XLogP | 6.25 |
| TPSA | 159.79 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 57 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 841.14 |
| LogP ≤ 5 | 6.25 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156662122 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.